{"gene":"REXO4","run_date":"2026-06-10T06:43:36","timeline":{"discoveries":[{"year":2000,"finding":"hPMC2 (REXO4) directly binds to the electrophile/antioxidant response element (EpRE) of the quinone reductase (QR) gene and interacts with estrogen receptor beta (ERβ > ERα) in yeast genetic screening and in vitro assays; hPMC2 alone can slightly activate EpRE-reporter activity, enhanced in the presence of ERβ.","method":"Yeast two-hybrid screening, in vitro binding assays, transient transfection reporter assays","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — yeast two-hybrid plus in vitro assay and reporter assay, single lab, multiple orthogonal methods","pmids":["10908561"],"is_preprint":false},{"year":2006,"finding":"p53 binds to the CpG island of the XPMC2H (REXO4) gene promoter under both DNA-damaging (adriamycin) and non-DNA-damaging (hypoxia) conditions, with binding occurring through both sequence-dependent and sequence-independent mechanisms.","method":"Chromatin immunoprecipitation (ChIP) followed by CpG island microarray hybridization and gene-specific PCR validation","journal":"Molecular and cellular biology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — ChIP-chip with gene-specific PCR validation, single lab, two orthogonal methods","pmids":["16980608"],"is_preprint":false},{"year":2008,"finding":"hPMC2 (REXO4) constitutively interacts with ERβ and is required for TOT-dependent co-recruitment of coactivators PARP-1 and Topoisomerase IIβ to the EpRE of the QR gene; absence of hPMC2 prevents PARP-1/TopoIIβ recruitment, loss of antioxidative enzyme induction, and attenuated protection against oxidative DNA damage.","method":"Co-immunoprecipitation, chromatin immunoprecipitation (ChIP), siRNA knockdown in breast epithelial cell lines with/without ERα","journal":"Oncogene","confidence":"High","confidence_rationale":"Tier 2 / Strong — reciprocal Co-IP, ChIP, and functional knockdown with defined molecular phenotype across multiple cell lines","pmids":["18663360"],"is_preprint":false},{"year":2011,"finding":"hPMC2 (REXO4) possesses intrinsic 3'-5' non-processive exonuclease activity that degrades both single-stranded and double-stranded DNA substrates in vitro; mutation of two conserved carboxylate residues in the C-terminal exonuclease domain drastically reduces this activity. This exonuclease activity is required for TOT-induced QR gene upregulation, for strand break formation at the EpRE, and for repair of estrogen-induced abasic sites. Nrf2 contributes to the specificity of hPMC2 for the EpRE.","method":"In vitro kinetic exonuclease assays, active-site mutagenesis, western blot for QR levels, chromatin immunoprecipitation (ChIP), abasic site repair assays","journal":"Oncogene","confidence":"High","confidence_rationale":"Tier 1 / Strong — in vitro kinetic assay with mutagenesis of catalytic residues, plus multiple functional readouts (ChIP, western blot, DNA repair assay), single lab but multiple orthogonal methods","pmids":["21602889"],"is_preprint":false},{"year":2015,"finding":"Downregulation of hPMC2 (REXO4) in triple-negative breast cancer cells increases cytotoxicity of the alkylating agent temozolomide (TMZ) and BCNU, associated with increased apurinic/apyrimidinic (AP) sites in DNA and elevated γ-H2AX levels (double-strand breaks), indicating hPMC2 is required for repair of alkylating agent-induced DNA damage.","method":"siRNA knockdown, cell viability assays, AP site quantification, western blot for γ-H2AX, immunofluorescence, comet assay","journal":"Cancer biology & therapy","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — knockdown with multiple orthogonal damage-readout assays (AP sites, γ-H2AX, comet assay), single lab","pmids":["25849309"],"is_preprint":false},{"year":2025,"finding":"REXO4 localizes to the nucleolus during interphase via an N-terminal nucleolar localization sequence, and to the perichromosomal layer of mitotic chromosomes in a Ki67-dependent manner. Depletion of REXO4 causes G1/S cell cycle arrest and reduced cell viability. REXO4 associates with ribosome components and proteins involved in rRNA metabolism, supporting a role in rRNA processing and ribosome biogenesis.","method":"Live-cell imaging, subcellular fractionation, deletion mutagenesis (N-terminal NLS), siRNA/shRNA depletion with cell cycle analysis (flow cytometry), co-immunoprecipitation/mass spectrometry protein-protein interaction network","journal":"bioRxiv","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — multiple orthogonal methods (localization, mutagenesis, depletion + cell cycle readout, interactome), single lab, preprint not peer-reviewed","pmids":["39829749"],"is_preprint":true},{"year":2025,"finding":"DDX18 physically interacts with REXO4 in hepatocellular carcinoma cells, and overexpression of REXO4 reverses the inhibitory effects of DDX18 knockdown on tumor growth and metastasis in vitro and in vivo, placing REXO4 downstream of DDX18 in the DDX18/REXO4 axis regulating EMT and MAPK signaling.","method":"Co-immunoprecipitation, immunofluorescence colocalization, overexpression rescue experiments, in vitro functional assays, nude mouse xenograft","journal":"Journal of gastrointestinal oncology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — reciprocal Co-IP with colocalization and in vivo rescue, single lab","pmids":["40950356"],"is_preprint":false},{"year":2025,"finding":"REXO4 is recruited to stress granules (SGs) in HeLa cells under heat shock stress, identified as a novel SG component with nuclear-cytoplasmic shuttling behavior.","method":"Antibody-guided proximity labeling (Ab-PL) proteomics in HeLa and RAW264.7 cells under multiple stress conditions","journal":"Analytical chemistry","confidence":"Low","confidence_rationale":"Tier 3 / Weak — single proximity labeling proteomics experiment, no functional validation of REXO4's role in SGs","pmids":["40198209"],"is_preprint":false},{"year":2026,"finding":"REXO4 directly degrades the RNA strand in R-loops from the end or internal nick via its 3'-5' exonuclease activity and stimulates RNaseH1 endonuclease activity, enabling an 'endo/exo-cleavage coupling' mode of R-loop processing. REXO4-regulated R-loop regions genome-wide highly overlap with those regulated by RNaseH1, and REXO4 overexpression counteracts genome-wide R-loop accumulation caused by RNaseH1 deficiency. Patient-derived tumor mutations in the REXO4 enzymatic region impair R-loop cleavage activity. A small-molecule inhibitor (REXO4-IN-17) inhibits REXO4 nuclease activity, and REXO4 interference sensitizes tumor cells to alkylating agents and activates cGAS-mediated antitumor immunity.","method":"In vitro exonuclease assays on R-loop substrates, RNaseH1 activity stimulation assays, genome-wide R-loop mapping (DRIP-seq), mutagenesis of patient-derived variants, small-molecule inhibitor assays, cGAS-STING pathway readouts","journal":"Science advances","confidence":"High","confidence_rationale":"Tier 1 / Strong — in vitro reconstitution of R-loop cleavage, mutagenesis, genome-wide orthogonal validation, and multiple functional readouts in one rigorous study","pmids":["41706852"],"is_preprint":false}],"current_model":"REXO4 (hPMC2/XPMC2H) is a 3'-5' non-processive exonuclease that degrades single- and double-stranded DNA/RNA substrates including the RNA strand of R-loops, acting in concert with RNaseH1 (which it stimulates) to resolve R-loops and prevent genome instability; it constitutively interacts with ERβ and is recruited to the EpRE of antioxidative enzyme genes (e.g., QR/NQO1) where its catalytic activity drives coactivator (PARP-1, TopoIIβ) assembly and gene induction, repairs estrogen-induced abasic sites, and contributes to DNA damage repair from alkylating agents; during interphase REXO4 localizes to the nucleolus via an N-terminal nucleolar localization sequence and associates with ribosome/rRNA processing factors, relocating to the perichromosomal layer in mitosis in a Ki67-dependent manner, with depletion causing G1/S arrest."},"narrative":{"mechanistic_narrative":"REXO4 (hPMC2/XPMC2H) is a 3'-5' non-processive exonuclease that maintains genome stability by degrading single- and double-stranded nucleic acid substrates and resolving R-loops [PMID:21602889, PMID:41706852]. Its catalytic activity depends on two conserved C-terminal carboxylate residues, and it degrades the RNA strand of R-loops from ends or internal nicks while stimulating RNaseH1 endonuclease activity, establishing an endo/exo-cleavage coupling mode of R-loop processing; REXO4-regulated R-loop regions genome-wide overlap with those controlled by RNaseH1, and REXO4 overexpression counteracts R-loop accumulation caused by RNaseH1 deficiency [PMID:21602889, PMID:41706852]. Through this nuclease function REXO4 also participates in DNA damage repair, being required to repair estrogen-induced abasic sites and alkylating-agent-induced lesions, with its loss increasing AP sites and γ-H2AX and sensitizing cells to temozolomide and BCNU [PMID:21602889, PMID:25849309]. In an estrogen-signaling context, REXO4 constitutively interacts with ERβ and binds the electrophile/antioxidant response element (EpRE) of antioxidative enzyme genes such as quinone reductase, where its exonuclease activity drives strand-break formation and tamoxifen-dependent co-recruitment of the coactivators PARP-1 and Topoisomerase IIβ to induce gene expression [PMID:10908561, PMID:18663360, PMID:21602889]. The REXO4 promoter is itself bound by p53 [PMID:16980608]. During interphase REXO4 localizes to the nucleolus and associates with ribosome and rRNA-processing factors, consistent with a role in ribosome biogenesis, and its depletion causes G1/S cell cycle arrest [PMID:39829749]. Patient-derived tumor mutations in the enzymatic region impair R-loop cleavage, and a small-molecule inhibitor (REXO4-IN-17) blocks its nuclease activity, with REXO4 interference activating cGAS-mediated antitumor immunity [PMID:41706852].","teleology":[{"year":2000,"claim":"Established REXO4/hPMC2 as a sequence-specific factor at the antioxidant response element and a partner of estrogen receptor beta, linking it to antioxidative gene regulation.","evidence":"Yeast two-hybrid, in vitro binding, and reporter assays for EpRE and ERβ interaction","pmids":["10908561"],"confidence":"Medium","gaps":["No biochemical activity for the protein itself was defined","Mechanism of EpRE binding specificity unresolved"]},{"year":2006,"claim":"Showed the REXO4 gene is a transcriptional target of p53, connecting its expression to stress and DNA-damage signaling.","evidence":"ChIP-chip with gene-specific PCR validation of p53 binding at the XPMC2H promoter CpG island","pmids":["16980608"],"confidence":"Medium","gaps":["Functional consequence of p53 binding on REXO4 expression not quantified","Sequence-independent binding mechanism unexplained"]},{"year":2008,"claim":"Defined REXO4 as a constitutive ERβ partner required to assemble coactivators at antioxidative gene promoters, giving it a concrete role in inducible cytoprotection.","evidence":"Reciprocal Co-IP, ChIP, and siRNA knockdown in breast epithelial lines with defined PARP-1/TopoIIβ recruitment phenotype","pmids":["18663360"],"confidence":"High","gaps":["Did not yet identify the enzymatic basis of REXO4's contribution","How strand breaks couple to coactivator recruitment unresolved"]},{"year":2011,"claim":"Identified REXO4 as an intrinsic 3'-5' non-processive exonuclease and tied this catalytic activity to gene induction, strand-break formation, and abasic-site repair.","evidence":"In vitro kinetic exonuclease assays with catalytic-residue mutagenesis plus ChIP, western blot, and abasic-site repair assays","pmids":["21602889"],"confidence":"High","gaps":["Physiological nucleic-acid substrates beyond reporter contexts not defined","Role of Nrf2 in directing specificity mechanistically incomplete"]},{"year":2015,"claim":"Extended REXO4's repair role to alkylating-agent damage, providing a rationale for targeting it to sensitize tumor cells.","evidence":"siRNA knockdown with viability, AP-site, γ-H2AX, and comet assays in triple-negative breast cancer cells","pmids":["25849309"],"confidence":"Medium","gaps":["Direct repair substrate at alkylated lesions not biochemically defined","Pathway placement relative to known BER/DSB repair unclear"]},{"year":2025,"claim":"Placed REXO4 in the nucleolus and ribosome-biogenesis machinery during interphase and at the perichromosomal layer in mitosis, broadening its cellular role beyond DNA repair.","evidence":"Live-cell imaging, NLS deletion mutagenesis, depletion with cell-cycle flow cytometry, and Co-IP/MS interactome (preprint)","pmids":["39829749"],"confidence":"Medium","gaps":["Direct rRNA-processing substrate not demonstrated","Mechanism linking nucleolar role to G1/S arrest unresolved","Preprint, not peer-reviewed"]},{"year":2025,"claim":"Identified REXO4 as a stress-granule component with nucleocytoplasmic shuttling, hinting at a cytoplasmic stress-response role.","evidence":"Antibody-guided proximity-labeling proteomics under heat shock in HeLa and RAW264.7 cells","pmids":["40198209"],"confidence":"Low","gaps":["No functional validation of REXO4's role in stress granules","Single proximity-labeling dataset without orthogonal confirmation"]},{"year":2025,"claim":"Positioned REXO4 downstream of DDX18 in a tumor-promoting axis affecting EMT and MAPK signaling in hepatocellular carcinoma.","evidence":"Reciprocal Co-IP, colocalization, overexpression rescue, and nude mouse xenograft","pmids":["40950356"],"confidence":"Medium","gaps":["Molecular mechanism connecting REXO4 to MAPK signaling unresolved","Whether the effect requires REXO4 nuclease activity not tested"]},{"year":2026,"claim":"Established REXO4 as an R-loop-resolving nuclease that couples with RNaseH1 genome-wide, and demonstrated its druggability and link to antitumor immunity.","evidence":"In vitro R-loop exonuclease and RNaseH1-stimulation assays, DRIP-seq, patient-variant mutagenesis, small-molecule inhibitor, and cGAS-STING readouts","pmids":["41706852"],"confidence":"High","gaps":["Structural basis of endo/exo coupling with RNaseH1 not resolved","How REXO4 is recruited to specific R-loop sites unknown"]},{"year":null,"claim":"It remains unresolved how REXO4's distinct activities — nucleolar rRNA processing, R-loop resolution, estrogen-driven gene induction, and stress-granule association — are coordinated and regulated within a single cell.","evidence":"","pmids":[],"confidence":"Medium","gaps":["No unifying model of how REXO4 is partitioned among nucleolar, R-loop, and EpRE functions","Recruitment and regulatory mechanisms across compartments uncharacterized"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0140097","term_label":"catalytic activity, acting on DNA","supporting_discovery_ids":[3,8]},{"term_id":"GO:0016787","term_label":"hydrolase activity","supporting_discovery_ids":[3,8]},{"term_id":"GO:0003677","term_label":"DNA binding","supporting_discovery_ids":[0,3]},{"term_id":"GO:0140098","term_label":"catalytic activity, acting on RNA","supporting_discovery_ids":[8]}],"localization":[{"term_id":"GO:0005730","term_label":"nucleolus","supporting_discovery_ids":[5]},{"term_id":"GO:0005634","term_label":"nucleus","supporting_discovery_ids":[2,5]}],"pathway":[{"term_id":"R-HSA-73894","term_label":"DNA Repair","supporting_discovery_ids":[3,4,8]},{"term_id":"R-HSA-8953854","term_label":"Metabolism of RNA","supporting_discovery_ids":[5]},{"term_id":"R-HSA-8953897","term_label":"Cellular responses to stimuli","supporting_discovery_ids":[2]}],"complexes":[],"partners":["ESR2","RNASEH1","PARP1","TOP2B","DDX18"],"other_free_text":[]}},"prefetch_data":{"uniprot":{"accession":"Q9GZR2","full_name":"RNA exonuclease 4","aliases":["Exonuclease XPMC2","Prevents mitotic catastrophe 2 protein homolog","hPMC2"],"length_aa":422,"mass_kda":46.7,"function":"","subcellular_location":"Nucleus, nucleolus","url":"https://www.uniprot.org/uniprotkb/Q9GZR2/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/REXO4","classification":"Not Classified","n_dependent_lines":2,"n_total_lines":1208,"dependency_fraction":0.0016556291390728477},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[{"gene":"IPO5","stoichiometry":0.2},{"gene":"NPM1","stoichiometry":0.2}],"url":"https://opencell.sf.czbiohub.org/search/REXO4","total_profiled":1310},"omim":[{"mim_id":"611930","title":"INTERFERON-STIMULATED EXONUCLEASE GENE 20-KD-LIKE 2; ISG20L2","url":"https://www.omim.org/entry/611930"},{"mim_id":"602930","title":"REX4 HOMOLOG, 3-PRIME,5-PRIME-EXONUCLEASE; REXO4","url":"https://www.omim.org/entry/602930"},{"mim_id":"176894","title":"PROTEIN KINASE, cGMP-DEPENDENT, REGULATORY, TYPE I; PRKG1","url":"https://www.omim.org/entry/176894"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Supported","locations":[{"location":"Nucleoplasm","reliability":"Supported"},{"location":"Nucleoli","reliability":"Supported"}],"tissue_specificity":"Low tissue specificity","tissue_distribution":"Detected in all","driving_tissues":[],"url":"https://www.proteinatlas.org/search/REXO4"},"hgnc":{"alias_symbol":["hPMC2"],"prev_symbol":["XPMC2H"]},"alphafold":{"accession":"Q9GZR2","domains":[{"cath_id":"-","chopping":"190-227","consensus_level":"medium","plddt":68.4395,"start":190,"end":227},{"cath_id":"3.30.420.10","chopping":"244-408","consensus_level":"high","plddt":95.9221,"start":244,"end":408}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/Q9GZR2","model_url":"https://alphafold.ebi.ac.uk/files/AF-Q9GZR2-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-Q9GZR2-F1-predicted_aligned_error_v6.png","plddt_mean":70.75},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=REXO4","jax_strain_url":"https://www.jax.org/strain/search?query=REXO4"},"sequence":{"accession":"Q9GZR2","fasta_url":"https://rest.uniprot.org/uniprotkb/Q9GZR2.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/Q9GZR2/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/Q9GZR2"}},"corpus_meta":[{"pmid":"32172300","id":"PMC_32172300","title":"A genomics approach to females with infertility and recurrent pregnancy loss.","date":"2020","source":"Human genetics","url":"https://pubmed.ncbi.nlm.nih.gov/32172300","citation_count":68,"is_preprint":false},{"pmid":"16980608","id":"PMC_16980608","title":"Functional analysis of p53 binding under differential stresses.","date":"2006","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/16980608","citation_count":58,"is_preprint":false},{"pmid":"10908561","id":"PMC_10908561","title":"Identification and characterization of a novel factor that regulates quinone reductase gene transcriptional activity.","date":"2000","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/10908561","citation_count":28,"is_preprint":false},{"pmid":"37913903","id":"PMC_37913903","title":"PROTAC derivatization of natural products for target identification and drug discovery: Design of evodiamine-based PROTACs as novel REXO4 degraders.","date":"2023","source":"Journal of advanced research","url":"https://pubmed.ncbi.nlm.nih.gov/37913903","citation_count":24,"is_preprint":false},{"pmid":"18663360","id":"PMC_18663360","title":"hPMC2 is required for recruiting an ERbeta coactivator complex to mediate transcriptional upregulation of NQO1 and protection against oxidative DNA damage by tamoxifen.","date":"2008","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/18663360","citation_count":14,"is_preprint":false},{"pmid":"21602889","id":"PMC_21602889","title":"The exonuclease activity of hPMC2 is required for transcriptional regulation of the QR gene and repair of estrogen-induced abasic sites.","date":"2011","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/21602889","citation_count":12,"is_preprint":false},{"pmid":"33258162","id":"PMC_33258162","title":"Hydroxypropyl methylcellulose or soy protein isolate-based edible, water-soluble, and antioxidant films for safflower oil packaging.","date":"2020","source":"Journal of food science","url":"https://pubmed.ncbi.nlm.nih.gov/33258162","citation_count":11,"is_preprint":false},{"pmid":"35070432","id":"PMC_35070432","title":"REXO4 acts as a biomarker and promotes hepatocellular carcinoma progression.","date":"2021","source":"Journal of gastrointestinal oncology","url":"https://pubmed.ncbi.nlm.nih.gov/35070432","citation_count":9,"is_preprint":false},{"pmid":"25849309","id":"PMC_25849309","title":"Downregulation of hPMC2 imparts chemotherapeutic sensitivity to alkylating agents in breast cancer cells.","date":"2015","source":"Cancer biology & therapy","url":"https://pubmed.ncbi.nlm.nih.gov/25849309","citation_count":7,"is_preprint":false},{"pmid":"9325058","id":"PMC_9325058","title":"Human XPMC2H: cDNA cloning, mapping to 9q34, genomic structure, and evaluation as TSC1.","date":"1997","source":"Genomics","url":"https://pubmed.ncbi.nlm.nih.gov/9325058","citation_count":6,"is_preprint":false},{"pmid":"27245436","id":"PMC_27245436","title":"Whole-exome identifies RXRG and TH germline variants in familial isolated prolactinoma.","date":"2016","source":"Cancer genetics","url":"https://pubmed.ncbi.nlm.nih.gov/27245436","citation_count":6,"is_preprint":false},{"pmid":"35954332","id":"PMC_35954332","title":"FOXD1 Is a Transcription Factor Important for Uveal Melanocyte Development and Associated with High-Risk Uveal Melanoma.","date":"2022","source":"Cancers","url":"https://pubmed.ncbi.nlm.nih.gov/35954332","citation_count":6,"is_preprint":false},{"pmid":"11196458","id":"PMC_11196458","title":"The application of high density microarray for analysis of mitogenic signaling and cell-cycle in the adrenal.","date":"2000","source":"Endocrine research","url":"https://pubmed.ncbi.nlm.nih.gov/11196458","citation_count":4,"is_preprint":false},{"pmid":"40198209","id":"PMC_40198209","title":"Revealing Stress Granule Compositional Heterogeneity through Antibody-Guided Proximity Labeling.","date":"2025","source":"Analytical chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/40198209","citation_count":3,"is_preprint":false},{"pmid":"36353099","id":"PMC_36353099","title":"Effects of exogenous melatonin on expressional differences of immune-related genes in cashmere goats.","date":"2022","source":"Frontiers in genetics","url":"https://pubmed.ncbi.nlm.nih.gov/36353099","citation_count":3,"is_preprint":false},{"pmid":"23795205","id":"PMC_23795205","title":"TARGETING THE GENOTOXIC EFFECTS OF ESTROGENS.","date":"2012","source":"Drug discovery today. Disease mechanisms","url":"https://pubmed.ncbi.nlm.nih.gov/23795205","citation_count":2,"is_preprint":false},{"pmid":"41706852","id":"PMC_41706852","title":"R-loop processing via REXO4-RNaseH1-mediated endo- and exo-cleavage coupling mode prevents genome instability and antitumor immunity.","date":"2026","source":"Science advances","url":"https://pubmed.ncbi.nlm.nih.gov/41706852","citation_count":0,"is_preprint":false},{"pmid":"39829749","id":"PMC_39829749","title":"Human REXO4 is Required for Cell Cycle Progression.","date":"2025","source":"bioRxiv : the preprint server for biology","url":"https://pubmed.ncbi.nlm.nih.gov/39829749","citation_count":0,"is_preprint":false},{"pmid":"40950356","id":"PMC_40950356","title":"DDX18 promotes growth and metastasis of hepatocellular carcinoma via activating EMT and MAPK signaling.","date":"2025","source":"Journal of gastrointestinal oncology","url":"https://pubmed.ncbi.nlm.nih.gov/40950356","citation_count":0,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":11222,"output_tokens":2687,"usd":0.036985,"stage1_stop_reason":"end_turn"},"stage2":{"model":"claude-opus-4-8","input_tokens":9860,"output_tokens":3338,"usd":0.066375,"stage2_stop_reason":"end_turn"},"total_usd":0.10336,"stage1_batch_id":"msgbatch_01CNoDbkChHEkgrJnL7BwtGJ","stage2_batch_id":"msgbatch_016Y4x9E9Wg5VQDANj9quSQD","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 2000,\n      \"finding\": \"hPMC2 (REXO4) directly binds to the electrophile/antioxidant response element (EpRE) of the quinone reductase (QR) gene and interacts with estrogen receptor beta (ERβ > ERα) in yeast genetic screening and in vitro assays; hPMC2 alone can slightly activate EpRE-reporter activity, enhanced in the presence of ERβ.\",\n      \"method\": \"Yeast two-hybrid screening, in vitro binding assays, transient transfection reporter assays\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — yeast two-hybrid plus in vitro assay and reporter assay, single lab, multiple orthogonal methods\",\n      \"pmids\": [\"10908561\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"p53 binds to the CpG island of the XPMC2H (REXO4) gene promoter under both DNA-damaging (adriamycin) and non-DNA-damaging (hypoxia) conditions, with binding occurring through both sequence-dependent and sequence-independent mechanisms.\",\n      \"method\": \"Chromatin immunoprecipitation (ChIP) followed by CpG island microarray hybridization and gene-specific PCR validation\",\n      \"journal\": \"Molecular and cellular biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — ChIP-chip with gene-specific PCR validation, single lab, two orthogonal methods\",\n      \"pmids\": [\"16980608\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"hPMC2 (REXO4) constitutively interacts with ERβ and is required for TOT-dependent co-recruitment of coactivators PARP-1 and Topoisomerase IIβ to the EpRE of the QR gene; absence of hPMC2 prevents PARP-1/TopoIIβ recruitment, loss of antioxidative enzyme induction, and attenuated protection against oxidative DNA damage.\",\n      \"method\": \"Co-immunoprecipitation, chromatin immunoprecipitation (ChIP), siRNA knockdown in breast epithelial cell lines with/without ERα\",\n      \"journal\": \"Oncogene\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — reciprocal Co-IP, ChIP, and functional knockdown with defined molecular phenotype across multiple cell lines\",\n      \"pmids\": [\"18663360\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"hPMC2 (REXO4) possesses intrinsic 3'-5' non-processive exonuclease activity that degrades both single-stranded and double-stranded DNA substrates in vitro; mutation of two conserved carboxylate residues in the C-terminal exonuclease domain drastically reduces this activity. This exonuclease activity is required for TOT-induced QR gene upregulation, for strand break formation at the EpRE, and for repair of estrogen-induced abasic sites. Nrf2 contributes to the specificity of hPMC2 for the EpRE.\",\n      \"method\": \"In vitro kinetic exonuclease assays, active-site mutagenesis, western blot for QR levels, chromatin immunoprecipitation (ChIP), abasic site repair assays\",\n      \"journal\": \"Oncogene\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — in vitro kinetic assay with mutagenesis of catalytic residues, plus multiple functional readouts (ChIP, western blot, DNA repair assay), single lab but multiple orthogonal methods\",\n      \"pmids\": [\"21602889\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"Downregulation of hPMC2 (REXO4) in triple-negative breast cancer cells increases cytotoxicity of the alkylating agent temozolomide (TMZ) and BCNU, associated with increased apurinic/apyrimidinic (AP) sites in DNA and elevated γ-H2AX levels (double-strand breaks), indicating hPMC2 is required for repair of alkylating agent-induced DNA damage.\",\n      \"method\": \"siRNA knockdown, cell viability assays, AP site quantification, western blot for γ-H2AX, immunofluorescence, comet assay\",\n      \"journal\": \"Cancer biology & therapy\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — knockdown with multiple orthogonal damage-readout assays (AP sites, γ-H2AX, comet assay), single lab\",\n      \"pmids\": [\"25849309\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"REXO4 localizes to the nucleolus during interphase via an N-terminal nucleolar localization sequence, and to the perichromosomal layer of mitotic chromosomes in a Ki67-dependent manner. Depletion of REXO4 causes G1/S cell cycle arrest and reduced cell viability. REXO4 associates with ribosome components and proteins involved in rRNA metabolism, supporting a role in rRNA processing and ribosome biogenesis.\",\n      \"method\": \"Live-cell imaging, subcellular fractionation, deletion mutagenesis (N-terminal NLS), siRNA/shRNA depletion with cell cycle analysis (flow cytometry), co-immunoprecipitation/mass spectrometry protein-protein interaction network\",\n      \"journal\": \"bioRxiv\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — multiple orthogonal methods (localization, mutagenesis, depletion + cell cycle readout, interactome), single lab, preprint not peer-reviewed\",\n      \"pmids\": [\"39829749\"],\n      \"is_preprint\": true\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"DDX18 physically interacts with REXO4 in hepatocellular carcinoma cells, and overexpression of REXO4 reverses the inhibitory effects of DDX18 knockdown on tumor growth and metastasis in vitro and in vivo, placing REXO4 downstream of DDX18 in the DDX18/REXO4 axis regulating EMT and MAPK signaling.\",\n      \"method\": \"Co-immunoprecipitation, immunofluorescence colocalization, overexpression rescue experiments, in vitro functional assays, nude mouse xenograft\",\n      \"journal\": \"Journal of gastrointestinal oncology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — reciprocal Co-IP with colocalization and in vivo rescue, single lab\",\n      \"pmids\": [\"40950356\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"REXO4 is recruited to stress granules (SGs) in HeLa cells under heat shock stress, identified as a novel SG component with nuclear-cytoplasmic shuttling behavior.\",\n      \"method\": \"Antibody-guided proximity labeling (Ab-PL) proteomics in HeLa and RAW264.7 cells under multiple stress conditions\",\n      \"journal\": \"Analytical chemistry\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 / Weak — single proximity labeling proteomics experiment, no functional validation of REXO4's role in SGs\",\n      \"pmids\": [\"40198209\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2026,\n      \"finding\": \"REXO4 directly degrades the RNA strand in R-loops from the end or internal nick via its 3'-5' exonuclease activity and stimulates RNaseH1 endonuclease activity, enabling an 'endo/exo-cleavage coupling' mode of R-loop processing. REXO4-regulated R-loop regions genome-wide highly overlap with those regulated by RNaseH1, and REXO4 overexpression counteracts genome-wide R-loop accumulation caused by RNaseH1 deficiency. Patient-derived tumor mutations in the REXO4 enzymatic region impair R-loop cleavage activity. A small-molecule inhibitor (REXO4-IN-17) inhibits REXO4 nuclease activity, and REXO4 interference sensitizes tumor cells to alkylating agents and activates cGAS-mediated antitumor immunity.\",\n      \"method\": \"In vitro exonuclease assays on R-loop substrates, RNaseH1 activity stimulation assays, genome-wide R-loop mapping (DRIP-seq), mutagenesis of patient-derived variants, small-molecule inhibitor assays, cGAS-STING pathway readouts\",\n      \"journal\": \"Science advances\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — in vitro reconstitution of R-loop cleavage, mutagenesis, genome-wide orthogonal validation, and multiple functional readouts in one rigorous study\",\n      \"pmids\": [\"41706852\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"REXO4 (hPMC2/XPMC2H) is a 3'-5' non-processive exonuclease that degrades single- and double-stranded DNA/RNA substrates including the RNA strand of R-loops, acting in concert with RNaseH1 (which it stimulates) to resolve R-loops and prevent genome instability; it constitutively interacts with ERβ and is recruited to the EpRE of antioxidative enzyme genes (e.g., QR/NQO1) where its catalytic activity drives coactivator (PARP-1, TopoIIβ) assembly and gene induction, repairs estrogen-induced abasic sites, and contributes to DNA damage repair from alkylating agents; during interphase REXO4 localizes to the nucleolus via an N-terminal nucleolar localization sequence and associates with ribosome/rRNA processing factors, relocating to the perichromosomal layer in mitosis in a Ki67-dependent manner, with depletion causing G1/S arrest.\"\n}\n```","stage2_raw":"{\n  \"mechanistic_narrative\": \"REXO4 (hPMC2/XPMC2H) is a 3'-5' non-processive exonuclease that maintains genome stability by degrading single- and double-stranded nucleic acid substrates and resolving R-loops [#3, #8]. Its catalytic activity depends on two conserved C-terminal carboxylate residues, and it degrades the RNA strand of R-loops from ends or internal nicks while stimulating RNaseH1 endonuclease activity, establishing an endo/exo-cleavage coupling mode of R-loop processing; REXO4-regulated R-loop regions genome-wide overlap with those controlled by RNaseH1, and REXO4 overexpression counteracts R-loop accumulation caused by RNaseH1 deficiency [#3, #8]. Through this nuclease function REXO4 also participates in DNA damage repair, being required to repair estrogen-induced abasic sites and alkylating-agent-induced lesions, with its loss increasing AP sites and γ-H2AX and sensitizing cells to temozolomide and BCNU [#3, #4]. In an estrogen-signaling context, REXO4 constitutively interacts with ERβ and binds the electrophile/antioxidant response element (EpRE) of antioxidative enzyme genes such as quinone reductase, where its exonuclease activity drives strand-break formation and tamoxifen-dependent co-recruitment of the coactivators PARP-1 and Topoisomerase IIβ to induce gene expression [#0, #2, #3]. The REXO4 promoter is itself bound by p53 [#1]. During interphase REXO4 localizes to the nucleolus and associates with ribosome and rRNA-processing factors, consistent with a role in ribosome biogenesis, and its depletion causes G1/S cell cycle arrest [#5]. Patient-derived tumor mutations in the enzymatic region impair R-loop cleavage, and a small-molecule inhibitor (REXO4-IN-17) blocks its nuclease activity, with REXO4 interference activating cGAS-mediated antitumor immunity [#8].\",\n  \"teleology\": [\n    {\n      \"year\": 2000,\n      \"claim\": \"Established REXO4/hPMC2 as a sequence-specific factor at the antioxidant response element and a partner of estrogen receptor beta, linking it to antioxidative gene regulation.\",\n      \"evidence\": \"Yeast two-hybrid, in vitro binding, and reporter assays for EpRE and ERβ interaction\",\n      \"pmids\": [\"10908561\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"No biochemical activity for the protein itself was defined\", \"Mechanism of EpRE binding specificity unresolved\"]\n    },\n    {\n      \"year\": 2006,\n      \"claim\": \"Showed the REXO4 gene is a transcriptional target of p53, connecting its expression to stress and DNA-damage signaling.\",\n      \"evidence\": \"ChIP-chip with gene-specific PCR validation of p53 binding at the XPMC2H promoter CpG island\",\n      \"pmids\": [\"16980608\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Functional consequence of p53 binding on REXO4 expression not quantified\", \"Sequence-independent binding mechanism unexplained\"]\n    },\n    {\n      \"year\": 2008,\n      \"claim\": \"Defined REXO4 as a constitutive ERβ partner required to assemble coactivators at antioxidative gene promoters, giving it a concrete role in inducible cytoprotection.\",\n      \"evidence\": \"Reciprocal Co-IP, ChIP, and siRNA knockdown in breast epithelial lines with defined PARP-1/TopoIIβ recruitment phenotype\",\n      \"pmids\": [\"18663360\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Did not yet identify the enzymatic basis of REXO4's contribution\", \"How strand breaks couple to coactivator recruitment unresolved\"]\n    },\n    {\n      \"year\": 2011,\n      \"claim\": \"Identified REXO4 as an intrinsic 3'-5' non-processive exonuclease and tied this catalytic activity to gene induction, strand-break formation, and abasic-site repair.\",\n      \"evidence\": \"In vitro kinetic exonuclease assays with catalytic-residue mutagenesis plus ChIP, western blot, and abasic-site repair assays\",\n      \"pmids\": [\"21602889\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Physiological nucleic-acid substrates beyond reporter contexts not defined\", \"Role of Nrf2 in directing specificity mechanistically incomplete\"]\n    },\n    {\n      \"year\": 2015,\n      \"claim\": \"Extended REXO4's repair role to alkylating-agent damage, providing a rationale for targeting it to sensitize tumor cells.\",\n      \"evidence\": \"siRNA knockdown with viability, AP-site, γ-H2AX, and comet assays in triple-negative breast cancer cells\",\n      \"pmids\": [\"25849309\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Direct repair substrate at alkylated lesions not biochemically defined\", \"Pathway placement relative to known BER/DSB repair unclear\"]\n    },\n    {\n      \"year\": 2025,\n      \"claim\": \"Placed REXO4 in the nucleolus and ribosome-biogenesis machinery during interphase and at the perichromosomal layer in mitosis, broadening its cellular role beyond DNA repair.\",\n      \"evidence\": \"Live-cell imaging, NLS deletion mutagenesis, depletion with cell-cycle flow cytometry, and Co-IP/MS interactome (preprint)\",\n      \"pmids\": [\"39829749\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Direct rRNA-processing substrate not demonstrated\", \"Mechanism linking nucleolar role to G1/S arrest unresolved\", \"Preprint, not peer-reviewed\"]\n    },\n    {\n      \"year\": 2025,\n      \"claim\": \"Identified REXO4 as a stress-granule component with nucleocytoplasmic shuttling, hinting at a cytoplasmic stress-response role.\",\n      \"evidence\": \"Antibody-guided proximity-labeling proteomics under heat shock in HeLa and RAW264.7 cells\",\n      \"pmids\": [\"40198209\"],\n      \"confidence\": \"Low\",\n      \"gaps\": [\"No functional validation of REXO4's role in stress granules\", \"Single proximity-labeling dataset without orthogonal confirmation\"]\n    },\n    {\n      \"year\": 2025,\n      \"claim\": \"Positioned REXO4 downstream of DDX18 in a tumor-promoting axis affecting EMT and MAPK signaling in hepatocellular carcinoma.\",\n      \"evidence\": \"Reciprocal Co-IP, colocalization, overexpression rescue, and nude mouse xenograft\",\n      \"pmids\": [\"40950356\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Molecular mechanism connecting REXO4 to MAPK signaling unresolved\", \"Whether the effect requires REXO4 nuclease activity not tested\"]\n    },\n    {\n      \"year\": 2026,\n      \"claim\": \"Established REXO4 as an R-loop-resolving nuclease that couples with RNaseH1 genome-wide, and demonstrated its druggability and link to antitumor immunity.\",\n      \"evidence\": \"In vitro R-loop exonuclease and RNaseH1-stimulation assays, DRIP-seq, patient-variant mutagenesis, small-molecule inhibitor, and cGAS-STING readouts\",\n      \"pmids\": [\"41706852\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Structural basis of endo/exo coupling with RNaseH1 not resolved\", \"How REXO4 is recruited to specific R-loop sites unknown\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"It remains unresolved how REXO4's distinct activities — nucleolar rRNA processing, R-loop resolution, estrogen-driven gene induction, and stress-granule association — are coordinated and regulated within a single cell.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"No unifying model of how REXO4 is partitioned among nucleolar, R-loop, and EpRE functions\", \"Recruitment and regulatory mechanisms across compartments uncharacterized\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0140097\", \"supporting_discovery_ids\": [3, 8]},\n      {\"term_id\": \"GO:0016787\", \"supporting_discovery_ids\": [3, 8]},\n      {\"term_id\": \"GO:0003677\", \"supporting_discovery_ids\": [0, 3]},\n      {\"term_id\": \"GO:0140098\", \"supporting_discovery_ids\": [8]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005730\", \"supporting_discovery_ids\": [5]},\n      {\"term_id\": \"GO:0005634\", \"supporting_discovery_ids\": [2, 5]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-73894\", \"supporting_discovery_ids\": [3, 4, 8]},\n      {\"term_id\": \"R-HSA-8953854\", \"supporting_discovery_ids\": [5]},\n      {\"term_id\": \"R-HSA-8953897\", \"supporting_discovery_ids\": [2]}\n    ],\n    \"complexes\": [],\n    \"partners\": [\"ESR2\", \"RNASEH1\", \"PARP1\", \"TOP2B\", \"DDX18\"],\n    \"other_free_text\": []\n  }\n}","audit_flag":null,"evaluation":{"faith_supported":7,"faith_total":7,"faith_pct":100.0}}